Publication | Closed Access

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study

Tumor ImmunologyCancer ImmunosurveillanceOncologic ImagingMedicineImmunologyImmune Checkpoint InhibitorRadiomicsRadiomics ApproachAnti-pd-l1 ImmunotherapyImmunotherapyOncologyTumor MicroenvironmentRadiologyImaging Biomarker